Valuation: Cencora, Inc.

Market Cap 58.57B 51.51B 48.69B 44.19B 82.99B 5,621B 83.47B 583B 225B 2,867B 220B 215B 9,216B P/E 2026 *
16.8x
P/E 2027 * 18.3x
Enterprise Value 66.26B 58.28B 55.08B 49.99B 93.89B 6,360B 94.43B 659B 255B 3,243B 249B 243B 10,426B EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.19x
Free-Float
61.21%
Yield 2026 *
0.77%
Yield 2027 * 0.79%
1 day-1.84%
1 week-0.04%
Current month-2.98%
1 month-4.20%
3 months+6.93%
6 months-2.32%
Current year-15.17%
1 week 266.8
Extreme 266.8
273.1
1 month 266.5
Extreme 266.5
287.1
Current year 212.9
Extreme 212.9
316.5
1 year 212.9
Extreme 212.9
327.1
3 years 171.2
Extreme 171.2
327.1
5 years 101
Extreme 101
327.1
10 years 58.64
Extreme 58.644
327.1
Manager TitleAgeSince
Chief Executive Officer 59 01/10/2024
Director of Finance/CFO 59 29/06/2026
Chief Tech/Sci/R&D Officer 50 04/11/2024
Director TitleAgeSince
Director/Board Member 75 16/05/2013
Director/Board Member 59 01/10/2024
Chairman 64 01/10/2025
Change 5-day change 1-year change 3-year change Capi.($)
-1.84%-0.04% - - 58.57B
-0.31%-1.59%-24.39%+5.71% 175B
+0.97%-2.85%-5.01%+14.42% 113B
-1.01%-1.61%-1.04%+64.08% 58.57B
+0.01%+1.60%-0.42%-28.97% 50.07B
+0.45%+4.36%+15.64%+53.13% 49.92B
+0.07%-2.99%+29.18%-5.87% 32.69B
+1.07%+10.84% - - 30.44B
+1.41%+3.68%+43.64%+0.13% 26.07B
+1.98%+9.34%+26.26%-2.43% 23.55B
Average +0.28%+1.76%+10.48%+12.52% 62.22B
Weighted average by Cap. +0.05%+0.01%-2.71%+13.87%

Financials

2026 *2027 *
Net sales 337B 296B 280B 254B 478B 32,347B 480B 3,353B 1,296B 16,495B 1,265B 1,238B 53,029B 353B 310B 293B 266B 500B 33,878B 503B 3,511B 1,357B 17,276B 1,325B 1,296B 55,540B
Net income 3.58B 3.15B 2.98B 2.7B 5.07B 344B 5.1B 35.62B 13.76B 175B 13.44B 13.15B 563B 2.84B 2.5B 2.37B 2.15B 4.03B 273B 4.05B 28.3B 10.94B 139B 10.68B 10.45B 448B
Net Debt 7.69B 6.76B 6.39B 5.8B 10.9B 738B 10.96B 76.51B 29.56B 376B 28.87B 28.25B 1,210B 9.44B 8.3B 7.85B 7.12B 13.37B 906B 13.45B 93.88B 36.28B 462B 35.43B 34.66B 1,485B
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Date Price Change
28/09/26 €266.80 -1.84%
25/09/26 €271.80 +0.07%
24/09/26 €271.60 -0.29%
23/09/26 €272.40 -0.26%
22/09/26 €273.10 +2.48%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
303.81USD
Average target price
369.25USD
Spread / Average Target
+21.54%

Quarterly revenue - Rate of surprise